BeSound key facts
as of Oct 2026- Developer of medical imaging devices designed to provide cancer diagnoses.
- BeSound is valued at approximately $8.0M as of Oct 2026 (last reported valuation).
- It has raised $9.2M; the latest was Seed Round ($6.8M) in Sep 2025.
- Notable investors include Mana Ventures, Lux Capital, Forum Ventures, Kindred Ventures, Arben Ventures — 15 tracked in total.
- Status: Privately Held (backing).
BeSound's last reported valuation, Jul 2023. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch BeSound: the Monday email on marks, rounds and moves
BeSound funding rounds
No funding rounds for BeSound are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
BeSound leadership
- Bailey RengerChief Executive Officer & Founder
- John StancoChief Technology Officer & Founder
Who backs BeSound
15+BeSound valuation
BeSound's last reported valuation was $8 million in Jul 2023. No priced round, secondary trade or fund mark has surfaced since.
BeSound investors
15 investors are on record for BeSound, including Mana Ventures, Lux Capital, Forum Ventures and Kindred Ventures. By type, the record holds 12 venture capital firms and 1 angel investor.
Who runs BeSound
2 people are listed on the BeSound team: 2 executives, including Bailey Renger (Chief Executive Officer) and John Stanco (Chief Technology Officer). 2 of them have a verified direct contact on file.
About BeSound
Developer of medical imaging devices designed to provide cancer diagnoses. The company specializes in providing an imaging technique that is accessible, high-resolution, and non-ionizing, enabling researchers to offer an accurate examination of cancer symptoms.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 4
- Website
- besoundbreast.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.